|
TPM4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.803400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.099600E-03 |
| Normal-vs-Stage2 |
8.543000E-03 |
| Normal-vs-Stage3 |
1.445760E-01 |
| Normal-vs-Stage4 |
6.121000E-01 |
| Stage1-vs-Stage2 |
5.094600E-01 |
| Stage1-vs-Stage3 |
6.590200E-02 |
| Stage1-vs-Stage4 |
4.047700E-02 |
| Stage2-vs-Stage3 |
8.219900E-02 |
| Stage2-vs-Stage4 |
3.281500E-02 |
| Stage3-vs-Stage4 |
4.407600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.627780E-02 |
| Normal-vs-AfricanAmerican |
1.261800E-02 |
| Normal-vs-Asian |
9.297200E-01 |
| Caucasian-vs-AfricanAmerican |
1.601450E-01 |
| Caucasian-vs-Asian |
4.390800E-01 |
| AfricanAmerican-vs-Asian |
2.499200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.410000E-02 |
| Normal-vs-Female |
5.899100E-03 |
| Male-vs-Female |
8.008400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.683000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.521600E-02 |
| Normal-vs-Age(61-80Yrs) |
7.858700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.108230E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.244480E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.415300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.803400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.161200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.943900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.518230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.203800E-01 |
| Normal-vs-Grade 2 |
2.909700E-02 |
| Normal-vs-Grade 3 |
1.776600E-03 |
| Normal-vs-Grade 4 |
4.449600E-01 |
| Grade 1-vs-Grade 2 |
6.375000E-01 |
| Grade 1-vs-Grade 3 |
2.708000E-01 |
| Grade 1-vs-Grade 4 |
3.012200E-01 |
| Grade 2-vs-Grade 3 |
8.544400E-02 |
| Grade 2-vs-Grade 4 |
2.356300E-03 |
| Grade 3-vs-Grade 4 |
8.37780000000343E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.387720E-04 |
| Normal-vs-ccB subtype |
8.809200E-01 |
| ccA subtype-vs-ccB subtype |
2.49610000446765E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.565930E-02 |
| Normal-vs-N1 |
5.636800E-01 |
| N0-vs-N1 |
5.039900E-02 |
|
|
